Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
about
Issues and challenges in the development of pneumococcal protein vaccinesRecent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targetsStructural insights into catalytic and substrate binding mechanisms of the strategic EndA nuclease from Streptococcus pneumoniaeA new structural paradigm in copper resistance in Streptococcus pneumoniaeSystemic disease during Streptococcus pneumoniae acute lung infection requires 12-lipoxygenase-dependent inflammationPre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biologyOverview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.Clinical and laboratory features of Streptococcus salivarius meningitis: a case report and literature review.Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.220D-F2 from Rubus ulmifolius kills Streptococcus pneumoniae planktonic cells and pneumococcal biofilms.Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based studyStreptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementationA case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine.Haemophilus influenzae type b as an important cause of culture-positive acute otitis media in young children in Thailand: a tympanocentesis-based, multi-center, cross-sectional study.Inhibition of competence development, horizontal gene transfer and virulence in Streptococcus pneumoniae by a modified competence stimulating peptide.Following in real time the impact of pneumococcal virulence factors in an acute mouse pneumonia model using bioluminescent bacteria.Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.Saturated alanine scanning mutagenesis of the pneumococcus competence stimulating peptide identifies analogs that inhibit genetic transformation.Instability of ackA (acetate kinase) mutations and their effects on acetyl phosphate and ATP amounts in Streptococcus pneumoniae D39.Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies.Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract.Serotype and genotype distribution among invasive Streptococcus pneumoniae isolates in Colombia, 2005-2010.Characterization of mutants deficient in the L,D-carboxypeptidase (DacB) and WalRK (VicRK) regulon, involved in peptidoglycan maturation of Streptococcus pneumoniae serotype 2 strain D39.Invasive pneumococcal diseases in children and adolescents--a single centre experienceRisk factors for death from invasive pneumococcal disease, Europe, 2010.Cloning, overexpression, purification, crystallization, and preliminary X-ray studies of SP_0149, the substrate binding protein of an ABC transporter from Streptococcus pneumoniaeRole of phosphoinositide 3-kinase-Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptorsEnhanced inflammation in aged mice following infection with Streptococcus pneumoniae is associated with decreased IL-10 and augmented chemokine production.Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.Evolution of antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from children with invasive and noninvasive pneumococcal diseases in Algeria from 2005 to 2012.Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study.Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogensActive Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisA longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine eraHigher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children.E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae.Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.Update on the clinical utility and optimal use of cefditorenA Novel Metallo-β-Lactamase Involved in the Ampicillin Resistance of Streptococcus pneumoniae ATCC 49136 Strain.Diagnosis of Upper and Lower Respiratory Tract Bacterial Infections with the Use of Multiplex PCR Assays.
P2860
Q26823701-92C8AB06-C41D-4B27-8F92-220635C831A0Q27009118-2652F15F-DAF8-4735-ABD0-17AB1B0A138AQ27666089-D6EAC48E-A749-4BED-B307-4BDF3A4CBE42Q27676018-B9824C22-4EBD-481A-8CB3-7539D23231C6Q28299715-D7A8CFC7-A3D1-4147-B4A6-469C3657490DQ28479048-13C56473-E63B-4C3F-948A-D942A6F76E32Q30358199-842BB04A-A538-4FDF-95CA-055C0ADB4EC4Q30470322-0C4AE15A-F23E-4EF2-AFBC-E2B688230C5DQ31063000-CF526DAB-6D12-4060-9A3F-A3E296FE696BQ31161118-DD6A09AE-C7E5-4B04-B22F-D87F421E5200Q32173923-19CA141C-4283-4DDC-88E9-9C7FC01C5FDFQ33721628-54C3B832-B980-414D-BE63-E0838591404EQ33776577-6D0ED884-7F56-42EE-9CC3-2F79F969A166Q33823089-0CCF5882-4963-42D0-BE2E-A3D7A35984D1Q34016260-4CDD874D-C2B1-467F-BE91-7157A84DED64Q34034995-B4FB118B-1453-4629-A6E9-856167D520E1Q34291235-834F1EE4-46DB-4E55-89BD-DB89222B81A1Q34427280-66A6A1CA-FFD4-4CF7-822C-90627ED3330EQ34433442-2C8AA4E0-11E4-4112-9DA9-ABF0FD86E915Q34784957-0957727C-6C05-498F-8F4B-8831378F99BCQ34932026-A4CA6D42-2F22-4A2F-A9A9-9FAD3D5364C4Q35084987-9191C464-4A7E-4ED0-AFAE-D98155BF1DADQ35095905-063DAD78-905D-455D-9D0E-EB7D942922D3Q35119564-BB21539F-6590-4108-8CF7-5D2E5D1DD861Q35130282-B4129245-B03C-4C58-B252-0F00E933C26FQ35131315-C5A95D4C-CB8B-421F-9BD7-D3FF57D8D73AQ35162960-7C349235-F346-4F99-BD5C-8DC951BC052EQ35178687-76EA3BB1-EA9D-4369-81CF-DD87E1C12B59Q35506907-9D08833C-1E70-4EB0-B5D0-2951CE3E78EBQ35763579-6875E1CA-9788-4F3E-B5EC-60848DED0585Q35806261-D40BFA2F-3039-48EC-908A-F6812501BFFCQ35806833-401AD16D-2D80-44DB-A1C5-2DB027BC5E13Q35826641-F93372A1-8C3D-4661-859C-79887707692CQ35887787-39A78FDD-A82D-4E70-850E-36E5D9EA9A03Q35915846-3B56E580-36C2-429E-9D49-9184FD0215FCQ35954130-5D50FF6F-ECD2-433B-9671-3E8D8639B4EFQ36005317-A0C578A3-9FF1-47F2-B3F8-A8169453DCC9Q36008860-C5374188-8F6B-4194-A811-F791ADE9A59BQ36026754-7538EE20-06A9-4015-9562-74BBE1E7A57DQ36335142-0A661620-CF14-4B65-A8EC-738ABDFC272E
P2860
Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@ast
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@en
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@nl
type
label
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@ast
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@en
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@nl
prefLabel
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@ast
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@en
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@nl
P1476
Streptococcus pneumoniae: epid ...... tance, and impact of vaccines.
@en
P2093
Joseph P Lynch
P304
P356
10.1097/MCP.0B013E3283385653
P577
2010-05-01T00:00:00Z